{"transactions":[{"id":2288210,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2022-04-29T20:51:53.000Z","date":"2022-04-28","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone."}],"balance_after":1000,"derivative":{"expiration_date":"2025-01-26","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001209191-22-026291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919122026291/doc4.xml","form_type":"4"}},{"id":2288209,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO"}}],"security":"Common Stock","published_at":"2022-04-29T20:51:53.000Z","date":"2022-04-28","kind":"tax_withholding","acquired":false,"shares":250,"price":7.43,"value":1857.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs."}],"balance_after":3502,"source":{"system":"sec-edgar","filing":"0001209191-22-026291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919122026291/doc4.xml","form_type":"4"}},{"id":2288208,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO"}}],"security":"Common Stock","published_at":"2022-04-29T20:51:53.000Z","date":"2022-04-28","kind":"exercise","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":3752,"source":{"system":"sec-edgar","filing":"0001209191-22-026291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919122026291/doc4.xml","form_type":"4"}},{"id":2439276,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-10T22:28:28.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest one-third on the first anniversary of January 3, 2022 and thereafter in monthly installments over 24 months."}],"balance_after":7500,"derivative":{"exercise_price":8.26,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-22-002724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919122002724/doc4.xml","form_type":"4"}},{"id":2439275,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2022-01-10T22:28:28.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone.  The PRSUs will lapse in full if achievement of such milestone is not met."}],"balance_after":7500,"derivative":{"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-22-002724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919122002724/doc4.xml","form_type":"4"}},{"id":2892549,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-28T21:27:18.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest 25% on the first anniversary of January 26, 2021 and thereafter in monthly installments over 36 months."}],"balance_after":8000,"derivative":{"exercise_price":13.09,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-21-005881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919121005881/doc4.xml","form_type":"4"}},{"id":2892548,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2021-01-28T21:27:18.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone.  The PRSUs will lapse in full if achievement of such milestone is not met."}],"balance_after":2000,"derivative":{"expiration_date":"2025-01-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-21-005881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919121005881/doc4.xml","form_type":"4"}},{"id":2976159,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-18T21:47:23.000Z","date":"2020-11-16","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the options 50% of the total shares underlying the option vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone.  The options will lapse in full if achievement of such milestone is not met."}],"balance_after":12000,"derivative":{"exercise_price":10.36,"expiration_date":"2030-11-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-059141","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919120059141/doc4.xml","form_type":"4"}},{"id":3297970,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CSO"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-30T22:00:44.000Z","date":"2020-01-28","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on the first anniversary of January 28, 2020 and thereafter in monthly installments over 36 months."}],"balance_after":200000,"derivative":{"exercise_price":0.56,"expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-005575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919120005575/doc4.xml","form_type":"4"}},{"id":3681669,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CSO"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-31T21:38:56.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the options 25% of the total shares underlying the option vest on the achievement of a performance-based milestone, and 75% vest in monthly installments over 24 months commencing one month from achievement of such milestone.  The options will lapse in full if achievement of such milestone is not met by mid-2019"}],"balance_after":10000,"derivative":{"exercise_price":1.42,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-006166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919119006166/doc4.xml","form_type":"4"}},{"id":3681668,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CSO"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-31T21:38:56.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on the first anniversary of January 29, 2019 and thereafter in monthly installments over 36 months."}],"balance_after":30000,"derivative":{"exercise_price":1.42,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-006166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919119006166/doc4.xml","form_type":"4"}},{"id":3810075,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CSO"}}],"security":"Stock Option (right to buy)","published_at":"2018-09-21T20:38:17.000Z","date":"2018-09-20","kind":"grant","acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a four year period commencing one month from September 20 2018."}],"balance_after":37000,"derivative":{"exercise_price":2.56,"expiration_date":"2028-09-20","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001209191-18-051896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919118051896/doc4.xml","form_type":"4"}},{"id":3859312,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CSO"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-30T19:56:30.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a four year period commencing one month from July 26 2018."}],"balance_after":20000,"derivative":{"exercise_price":3.37,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-044355","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919118044355/doc4.xml","form_type":"4"}},{"id":4236891,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CSO"}}],"security":"Common Stock","published_at":"2017-08-11T18:18:12.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":176418,"ownership":{"direct":false,"nature":"By Ricanto Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This amended Form 4 is filed to include the number of common shares received in exchange for 491 common shares of Achieve pursuant to the Merger.  On the effective date of the Merger, the closing price of Achieve's common stock was $4.576 per share, representing a closing price of $0.416 per share of OncoGenex's common stock as adjusted to reflect the Reverse Stock Split."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The reporting holder is a principal owner of Ricanto Limited."}],"balance_after":176418,"source":{"system":"sec-edgar","filing":"0001209191-17-048552","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919117048552/doc4a.xml","form_type":"4/A","original_submission_date":"2017-08-03"}},{"id":4236890,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CSO"}}],"security":"Common Stock","published_at":"2017-08-11T18:18:12.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":538958,"ownership":{"direct":false,"nature":"By Son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This amended Form 4 is filed to correct the number of common shares received in exchange for 1,500 common shares of Achieve pursuant to the Merger. On the effective date of the Merger, the closing price of Achieve's common stock was $4.576 per share, representing a closing price of $0.416 per share of OncoGenex's common stock as adjusted to reflect the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This amended Form 4 is filed to correct the number of common shares received in exchange for 1,500 common shares of Achieve pursuant to the Merger. On the effective date of the Merger, the closing price of Achieve's common stock was $4.576 per share, representing a closing price of $0.416 per share of OncoGenex's common stock as adjusted to reflect the Reverse Stock Split."}],"balance_after":538958,"source":{"system":"sec-edgar","filing":"0001209191-17-048552","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919117048552/doc4a.xml","form_type":"4/A","original_submission_date":"2017-08-03"}},{"id":4236889,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CSO"}}],"security":"Common Stock","published_at":"2017-08-11T18:18:12.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":359305,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This amended Form 4 is filed to correct the number of common shares received in exchange for 1,000 common shares of Achieve pursuant to the Merger. On the effective date of the Merger, the closing price of Achieve's common stock was $4.576 per share, representing a closing price of $0.416 per share of OncoGenex's common stock as adjusted to reflect the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This amended Form 4 is filed to correct the number of common shares received in exchange for 1,000 common shares of Achieve pursuant to the Merger. On the effective date of the Merger, the closing price of Achieve's common stock was $4.576 per share, representing a closing price of $0.416 per share of OncoGenex's common stock as adjusted to reflect the Reverse Stock Split."}],"balance_after":359305,"source":{"system":"sec-edgar","filing":"0001209191-17-048552","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919117048552/doc4a.xml","form_type":"4/A","original_submission_date":"2017-08-03"}},{"id":4236888,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CSO"}}],"security":"Common Stock","published_at":"2017-08-11T18:18:12.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":550455,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is filed to correct the number of common shares received in exchange for 1,532 common shares of Achieve Life Science, Inc. (\"Achieve\") pursuant to the merger between OncoGenex Pharmaceuticals, Inc. (\"OncoGenex\") and Achieve (the \"Merger\"). On the effective date of the Merger, the closing price of Achieve's common stock was $4.576 per share, representing a closing price of $0.416 per share of OncoGenex's common stock as adjusted to reflect an 11-for-1 reverse stock split effected on August 1, 2017 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This amended Form 4 is filed to correct the number of common shares received in exchange for 1,532 common shares of Achieve Life Science, Inc. (\"Achieve\") pursuant to the merger between OncoGenex Pharmaceuticals, Inc. (\"OncoGenex\") and Achieve (the \"Merger\"). On the effective date of the Merger, the closing price of Achieve's common stock was $4.576 per share, representing a closing price of $0.416 per share of OncoGenex's common stock as adjusted to reflect an 11-for-1 reverse stock split effected on August 1, 2017 (the \"Reverse Stock Split\")."}],"balance_after":550455,"source":{"system":"sec-edgar","filing":"0001209191-17-048552","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919117048552/doc4a.xml","form_type":"4/A","original_submission_date":"2017-08-03"}},{"id":4244375,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-08-04T00:46:40.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":6364335,"ownership":{"direct":false,"nature":"By Son"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 1,500 common shares of Achieve Life Science, Inc. (\"Achieve\") pursuant to the merger between OncoGenex Pharmaceuticals, Inc. (\"OncoGenex\") and Achieve (the \"Merger\"). On the effective date of the Merger, the closing price of Achieve's common stock was $4.576 per share, representing a closing price of $0.416 per share of OncoGenex's common stock as adjusted to reflect an 11-for-1 reverse stock split effected on August 1, 2017 (the \"Reverse Stock Split\")."}],"balance_after":6364335,"source":{"system":"sec-edgar","filing":"0001209191-17-047582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919117047582/doc4.xml","form_type":"4"}},{"id":4244374,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-08-04T00:46:40.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":4242890,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for 1,000 common shares of Achieve pursuant to the Merger between OncoGenex and Achieve. On the effective date of the Merger, the closing price of Achieve's common stock was $4.576 per share, representing a closing price of $0.416 per share of OncoGenex's common stock as adjusted to reflect the Reverse Stock Split."}],"balance_after":4242890,"source":{"system":"sec-edgar","filing":"0001209191-17-047582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919117047582/doc4.xml","form_type":"4"}},{"id":4244373,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":127764,"kind":"person","name":"Clarke Anthony","position":1,"cik":"0001713368","reported_name":"Clarke Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-08-04T00:46:40.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":6364335,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 1,500 common shares of Achieve Life Science, Inc. (\"Achieve\") pursuant to the merger between OncoGenex Pharmaceuticals, Inc. (\"OncoGenex\") and Achieve (the \"Merger\"). On the effective date of the Merger, the closing price of Achieve's common stock was $4.576 per share, representing a closing price of $0.416 per share of OncoGenex's common stock as adjusted to reflect an 11-for-1 reverse stock split effected on August 1, 2017 (the \"Reverse Stock Split\")."}],"balance_after":6364335,"source":{"system":"sec-edgar","filing":"0001209191-17-047582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919117047582/doc4.xml","form_type":"4"}}]}